NM_001164507.2:c.24874-47A>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001164507.2(NEB):c.24874-47A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.328 in 1,593,840 control chromosomes in the GnomAD database, including 89,955 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.26 ( 6203 hom., cov: 31)
Exomes 𝑓: 0.33 ( 83752 hom. )
Consequence
NEB
NM_001164507.2 intron
NM_001164507.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.887
Publications
11 publications found
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
RIF1 (HGNC:23207): (replication timing regulatory factor 1) This gene encodes a protein that shares homology with the yeast teleomere binding protein, Rap1 interacting factor 1. This protein localizes to aberrant telomeres may be involved in DNA repair. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-151492328-T-A is Benign according to our data. Variant chr2-151492328-T-A is described in ClinVar as Benign. ClinVar VariationId is 257804.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.352 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NEB | ENST00000397345.8 | c.24874-47A>T | intron_variant | Intron 177 of 181 | 5 | NM_001164508.2 | ENSP00000380505.3 | |||
| NEB | ENST00000427231.7 | c.24874-47A>T | intron_variant | Intron 177 of 181 | 5 | NM_001164507.2 | ENSP00000416578.2 |
Frequencies
GnomAD3 genomes AF: 0.261 AC: 39680AN: 151960Hom.: 6197 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
39680
AN:
151960
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.301 AC: 71191AN: 236906 AF XY: 0.299 show subpopulations
GnomAD2 exomes
AF:
AC:
71191
AN:
236906
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.335 AC: 482412AN: 1441762Hom.: 83752 Cov.: 30 AF XY: 0.330 AC XY: 236330AN XY: 715206 show subpopulations
GnomAD4 exome
AF:
AC:
482412
AN:
1441762
Hom.:
Cov.:
30
AF XY:
AC XY:
236330
AN XY:
715206
show subpopulations
African (AFR)
AF:
AC:
2344
AN:
32914
American (AMR)
AF:
AC:
13645
AN:
43222
Ashkenazi Jewish (ASJ)
AF:
AC:
6139
AN:
24964
East Asian (EAS)
AF:
AC:
11023
AN:
39476
South Asian (SAS)
AF:
AC:
16892
AN:
83758
European-Finnish (FIN)
AF:
AC:
18461
AN:
52684
Middle Eastern (MID)
AF:
AC:
1639
AN:
5646
European-Non Finnish (NFE)
AF:
AC:
394053
AN:
1099636
Other (OTH)
AF:
AC:
18216
AN:
59462
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
16874
33748
50622
67496
84370
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
12498
24996
37494
49992
62490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.261 AC: 39690AN: 152078Hom.: 6203 Cov.: 31 AF XY: 0.261 AC XY: 19380AN XY: 74324 show subpopulations
GnomAD4 genome
AF:
AC:
39690
AN:
152078
Hom.:
Cov.:
31
AF XY:
AC XY:
19380
AN XY:
74324
show subpopulations
African (AFR)
AF:
AC:
3400
AN:
41516
American (AMR)
AF:
AC:
4380
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
AC:
827
AN:
3470
East Asian (EAS)
AF:
AC:
1328
AN:
5174
South Asian (SAS)
AF:
AC:
975
AN:
4816
European-Finnish (FIN)
AF:
AC:
3798
AN:
10552
Middle Eastern (MID)
AF:
AC:
90
AN:
294
European-Non Finnish (NFE)
AF:
AC:
24205
AN:
67982
Other (OTH)
AF:
AC:
561
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1387
2774
4162
5549
6936
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
412
824
1236
1648
2060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
793
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nemaline myopathy 2 Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Arthrogryposis multiplex congenita 6 Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.